Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
CRVL 
CorVel Corp (CRVL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: CRVL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -29% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 5.33B USD | Price to earnings Ratio 56.61 | 1Y Target Price - |
Price to earnings Ratio 56.61 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.02 | 52 Weeks Range 83.37 - 128.61 | Updated Date 06/29/2025 |
52 Weeks Range 83.37 - 128.61 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.83 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.63% | Operating Margin (TTM) 14.39% |
Management Effectiveness
Return on Assets (TTM) 15.09% | Return on Equity (TTM) 33.41% |
Valuation
Trailing PE 56.61 | Forward PE - | Enterprise Value 5181116845 | Price to Sales(TTM) 5.95 |
Enterprise Value 5181116845 | Price to Sales(TTM) 5.95 | ||
Enterprise Value to Revenue 5.79 | Enterprise Value to EBITDA 34.46 | Shares Outstanding 51440900 | Shares Floating 28823140 |
Shares Outstanding 51440900 | Shares Floating 28823140 | ||
Percent Insiders 43.82 | Percent Institutions 54.01 |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
CorVel Corp
Company Overview
History and Background
CorVel Corp. was founded in 1987. It provides risk management solutions to employers, insurance companies, and government entities. Initially focused on managed care, CorVel has expanded its offerings to include broader healthcare management and claims processing services.
Core Business Areas
- Managed Care: Provides network solutions, utilization review, and case management services to control healthcare costs.
- Claims Management: Offers claims processing, bill review, and related services to streamline and manage workers' compensation and auto liability claims.
- Care Management: Delivers care management, condition management, and other interventions to improve health outcomes and reduce costs.
Leadership and Structure
CorVel is led by Michael Combs (President and CEO). The organizational structure consists of various departments specializing in sales, operations, technology, and finance.
Top Products and Market Share
Key Offerings
- Care Management Services: Focus on improving patient outcomes, and reducing treatment costs. Market share data is not publicly available. Competitors include EXL Health, and Signify Health
- Claims Processing: Automates the claims process and improves accuracy. Market share data is not publicly available. Competitors include Gallagher Bassett, Broadspire, and Sedgwick.
- Network Solutions: Provides access to a network of healthcare providers with negotiated rates. Market share data is not publicly available. Competitors include Optum, Conduent, and Sedgwick.
Market Dynamics
Industry Overview
The risk management and healthcare management industry is experiencing growth driven by rising healthcare costs, regulatory changes, and the increasing need for efficiency and cost containment.
Positioning
CorVel is positioned as a provider of integrated risk management solutions with a focus on technology and data analytics. Competitive advantages include their proprietary technology platform and integrated service offerings.
Total Addressable Market (TAM)
The TAM for healthcare cost containment is estimated at over $100 billion. CorVel is positioned to capture a portion of this market through its comprehensive solutions and focus on data analytics.
Upturn SWOT Analysis
Strengths
- Integrated service offerings
- Proprietary technology platform
- Strong client relationships
- Expertise in data analytics
Weaknesses
- Reliance on key clients
- Exposure to regulatory changes
- Competitive landscape
- Lack of public market share data for offerings
Opportunities
- Expansion into new markets
- Development of new products and services
- Strategic acquisitions
- Increased demand for healthcare cost containment solutions
Threats
- Economic downturn
- Increased competition
- Changes in healthcare regulations
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- WLTW
- GHL
- HSIC
- MED
- UNH
Competitive Landscape
CorVel's advantages compared to competitors include its integrated service offerings and proprietary technology platform. Disadvantages include its smaller size and limited brand recognition.
Major Acquisitions
Tmesys Inc
- Year: 2007
- Acquisition Price (USD millions): 12.5
- Strategic Rationale: To enhance their medical information review and technology capabilities.
Growth Trajectory and Initiatives
Historical Growth: CorVel has experienced consistent revenue growth over the past years, driven by organic expansion and strategic acquisitions.
Future Projections: Analysts project continued revenue growth for CorVel, supported by increasing demand for healthcare cost containment solutions and expansion into new markets.
Recent Initiatives: Recent initiatives include the development of new data analytics tools and the expansion of the company's network of healthcare providers.
Summary
CorVel Corp is a stable company with consistent growth in revenue and net income. Its integrated service offerings and proprietary technology platform provide a competitive edge. Key opportunities lie in market expansion and new product development, but the company faces threats from competition and regulatory changes. Solid financial health and a positive growth trajectory position CorVel well for future success, but smaller size versus the competition is a hinderance.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website
- Analyst Reports
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It should not be considered investment advice. Market share data is based on general estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CorVel Corp
Exchange NASDAQ | Headquaters Fort Worth, TX, United States | ||
IPO Launch date 1991-06-28 | President, CEO & Chairman Mr. Michael G. Combs | ||
Sector Financial Services | Industry Insurance Brokers | Full time employees 5075 | Website https://www.corvel.com |
Full time employees 5075 | Website https://www.corvel.com | ||
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.